Question 1

What is the catalog number for N-Benzyl-2-bromo-4-methylbenzenesulfonamide?

Accepted Answer

The catalog number for N-Benzyl-2-bromo-4-methylbenzenesulfonamide is OR1052680.

Question 2

What sizes are available for N-Benzyl-2-bromo-4-methylbenzenesulfonamide?

Accepted Answer

N-Benzyl-2-bromo-4-methylbenzenesulfonamide is available in the following size(s): 250 mg, 1 g, 5 g.

Question 3

How many pack sizes does N-Benzyl-2-bromo-4-methylbenzenesulfonamide come in?

Accepted Answer

N-Benzyl-2-bromo-4-methylbenzenesulfonamide is available in 3 different pack sizes.

Question 4

Is N-Benzyl-2-bromo-4-methylbenzenesulfonamide in stock?

Accepted Answer

N-Benzyl-2-bromo-4-methylbenzenesulfonamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Question 7

Can this product be used in multiplex assays?

Accepted Answer

Multiplex compatibility depends on the specific product and detection panel. Contact our technical support team with details of your multiplex system for guidance before ordering.

N-Benzyl-2-bromo-4-methylbenzenesulfonamide

Product Specifications

CAS Number

MDL Number

Purity

Smiles

Available Sizes

Frequently Asked Questions

Explore Other Products

Pmel17 / gp100 / SILV (NKI-beteb), CF594 conjugate, 0.1mg/mL

Complement C4d (C4D204), CF640R conjugate, 0.1mg/mL

CD59 (heavy chain of Protectin) (BRA-10G), CF647 conjugate, 0.1mg/mL

CD53 (161-2), CF647 conjugate, 0.1mg/mL

CD104 (UM-A9), CF488A conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL